Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis
PF:AutovsPRP
Is There Any Advantage of PRP Over Autologous Blood Injection in the Treatment of Chronic Plantar Fasciitis? A Prospective Randomized Double Blinded Study
1 other identifier
interventional
60
1 country
1
Brief Summary
To explore effects of Autologous Blood Injection versus Platelet Rich plasma injection for treatment of chronic plantar fasciitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2022
CompletedFirst Submitted
Initial submission to the registry
February 13, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedMarch 2, 2022
February 1, 2022
8 months
February 13, 2022
February 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Changes in Visual Analogue Scale (VAS)
Visual Analogue Scale 10 worst 0-1 best in terms of pain outcome
0,1 st 3rd and 6th month; changes between time points will be assessed
Changes in American Orthopaedic Foot & Ankle Society (AOFAS ) Score
American Orthopaedic Foot \& Ankle Society (AOFAS) Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes Evaluation:0 worst 100 best
0,1 st 3rd and 6th month; changes between time points will be assessed
Changes in Foot and Ankle Disability Index (FADI)
Foot and Ankle Disability Index Evaluation:0 worst 100 best
0,1 st 3rd and 6th month; changes between time points will be assessed
Study Arms (2)
Group A
ACTIVE COMPARATORPlatelet Rich Plasm (PRP) injection group
Group B
ACTIVE COMPARATORAutologous Blood injection (ABI) group
Interventions
Eligibility Criteria
You may qualify if:
- Participants who were diagnosed with chronic plantar fasciitis
- Nonresponded to o conservative treatment (stretching exercises, nonsteroidal anti-inflammatory drugs, and heel pads) for at least 6 weeks
- Patient should be able to understand the informed consent about type of treatment and blindness and randomization
- Visual analog scale pain higher than 5 (on a 10-point visual analog scale)
You may not qualify if:
- previous history of any type of local injection treatment for heel pain
- history of surgery for heel pain, foot and ankle disorders, fractures
- Associated pathology involving the lower limb such as
- tarsal tunnel syndrome
- effusion of the ankle indicating an intra-articular disease
- Peroneal/Achilles/tibialis tendons pathology
- any obvious deformity of foot and ankle,
- Patients with systemic disorder like diabetes mellitus, ankylosing spondylitis rheumatoid arthritis, hematological disease, or gout
- Pregnancy
- Use of antiocoagulation -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atasehir Florence Nightingale Hospital
AtaÅŸehir, Istanbul, 34750, Turkey (TĂ¼rkiye)
Related Publications (26)
Kalia RB, Singh V, Chowdhury N, Jain A, Singh SK, Das L. Role of Platelet Rich Plasma in Chronic Plantar Fasciitis: A Prospective Study. Indian J Orthop. 2020 Oct 6;55(Suppl 1):142-148. doi: 10.1007/s43465-020-00261-w. eCollection 2021 May.
PMID: 34122767BACKGROUNDLatt LD, Jaffe DE, Tang Y, Taljanovic MS. Evaluation and Treatment of Chronic Plantar Fasciitis. Foot Ankle Orthop. 2020 Feb 13;5(1):2473011419896763. doi: 10.1177/2473011419896763. eCollection 2020 Jan.
PMID: 35097359BACKGROUNDBagcier F, Yilmaz N. The Impact of Extracorporeal Shock Wave Therapy and Dry Needling Combination on Pain and Functionality in the Patients Diagnosed with Plantar Fasciitis. J Foot Ankle Surg. 2020 Jul-Aug;59(4):689-693. doi: 10.1053/j.jfas.2019.09.038. Epub 2020 Apr 25.
PMID: 32340838BACKGROUNDLandorf KB. Plantar heel pain and plantar fasciitis. BMJ Clin Evid. 2015 Nov 25;2015:1111.
PMID: 26609884BACKGROUNDStuber K, Kristmanson K. Conservative therapy for plantar fasciitis: a narrative review of randomized controlled trials. J Can Chiropr Assoc. 2006 Jun;50(2):118-33.
PMID: 17549177BACKGROUNDMartin JE, Hosch JC, Goforth WP, Murff RT, Lynch DM, Odom RD. Mechanical treatment of plantar fasciitis. A prospective study. J Am Podiatr Med Assoc. 2001 Feb;91(2):55-62. doi: 10.7547/87507315-91-2-55.
PMID: 11266478BACKGROUNDKaya O, Hurel C, Gumussuyu G, Kose O. Bilateral calcaneal insufficiency fractures due to chronic carbamazepine use for trigeminal neuralgia: A case report. Niger J Clin Pract. 2020 Apr;23(4):574-576. doi: 10.4103/njcp.njcp_515_18.
PMID: 32246668BACKGROUNDGupta R, Malhotra A, Masih GD, Khanna T, Kaur H, Gupta P, Kashyap S. Comparing the Role of Different Treatment Modalities for Plantar Fasciitis: A Double Blind Randomized Controlled Trial. Indian J Orthop. 2020 Jan 20;54(1):31-37. doi: 10.1007/s43465-019-00038-w. eCollection 2020 Feb.
PMID: 32257015BACKGROUNDMahindra P, Yamin M, Selhi HS, Singla S, Soni A. Chronic Plantar Fasciitis: Effect of Platelet-Rich Plasma, Corticosteroid, and Placebo. Orthopedics. 2016 Mar-Apr;39(2):e285-9. doi: 10.3928/01477447-20160222-01. Epub 2016 Feb 25.
PMID: 26913766BACKGROUNDSingh P, Madanipour S, Bhamra JS, Gill I. A systematic review and meta-analysis of platelet-rich plasma versus corticosteroid injections for plantar fasciopathy. Int Orthop. 2017 Jun;41(6):1169-1181. doi: 10.1007/s00264-017-3470-x. Epub 2017 Apr 10.
PMID: 28396927BACKGROUNDJain SK, Suprashant K, Kumar S, Yadav A, Kearns SR. Comparison of Plantar Fasciitis Injected With Platelet-Rich Plasma vs Corticosteroids. Foot Ankle Int. 2018 Jul;39(7):780-786. doi: 10.1177/1071100718762406. Epub 2018 Mar 30.
PMID: 29600719BACKGROUNDYu T, Xia J, Li B, Zhou H, Yang Y, Yu G. Outcomes of platelet-rich plasma for plantar fasciopathy: a best-evidence synthesis. J Orthop Surg Res. 2020 Sep 21;15(1):432. doi: 10.1186/s13018-020-01783-7.
PMID: 32958046BACKGROUNDThomas JL, Christensen JC, Kravitz SR, Mendicino RW, Schuberth JM, Vanore JV, Weil LS Sr, Zlotoff HJ, Bouche R, Baker J; American College of Foot and Ankle Surgeons heel pain committee. The diagnosis and treatment of heel pain: a clinical practice guideline-revision 2010. J Foot Ankle Surg. 2010 May-Jun;49(3 Suppl):S1-19. doi: 10.1053/j.jfas.2010.01.001.
PMID: 20439021BACKGROUNDShetty SH, Dhond A, Arora M, Deore S. Platelet-Rich Plasma Has Better Long-Term Results Than Corticosteroids or Placebo for Chronic Plantar Fasciitis: Randomized Control Trial. J Foot Ankle Surg. 2019 Jan;58(1):42-46. doi: 10.1053/j.jfas.2018.07.006. Epub 2018 Nov 15.
PMID: 30448183BACKGROUNDCrawford F, Atkins D, Young P, Edwards J. Steroid injection for heel pain: evidence of short-term effectiveness. A randomized controlled trial. Rheumatology (Oxford). 1999 Oct;38(10):974-7. doi: 10.1093/rheumatology/38.10.974.
PMID: 10534548BACKGROUNDTsai WC, Hsu CC, Chen CP, Chen MJ, Yu TY, Chen YJ. Plantar fasciitis treated with local steroid injection: comparison between sonographic and palpation guidance. J Clin Ultrasound. 2006 Jan;34(1):12-6. doi: 10.1002/jcu.20177.
PMID: 16353228BACKGROUNDTatli YZ, Kapasi S. The real risks of steroid injection for plantar fasciitis, with a review of conservative therapies. Curr Rev Musculoskelet Med. 2009 Mar;2(1):3-9. doi: 10.1007/s12178-008-9036-1. Epub 2008 Sep 19.
PMID: 19468912BACKGROUNDArnoczky SP, Sheibani-Rad S. The basic science of platelet-rich plasma (PRP): what clinicians need to know. Sports Med Arthrosc Rev. 2013 Dec;21(4):180-5. doi: 10.1097/JSA.0b013e3182999712.
PMID: 24212364BACKGROUNDFoster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009 Nov;37(11):2259-72. doi: 10.1177/0363546509349921.
PMID: 19875361BACKGROUNDHall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009 Oct;17(10):602-8. doi: 10.5435/00124635-200910000-00002.
PMID: 19794217BACKGROUNDRagab EM, Othman AM. Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg. 2012 Aug;132(8):1065-70. doi: 10.1007/s00402-012-1505-8. Epub 2012 May 4.
PMID: 22555761BACKGROUNDMartinelli N, Marinozzi A, Carni S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop. 2013 May;37(5):839-42. doi: 10.1007/s00264-012-1741-0. Epub 2012 Dec 19.
PMID: 23250352BACKGROUNDWheeler PC, Dudson C. Similar Benefits Seen After Radial Extracorporeal Shockwave Therapy or Autologous Blood Injection in Patients With Chronic Plantar Fasciitis-A Retrospective Cohort Study. Clin J Sport Med. 2022 Mar 1;32(2):e107-e115. doi: 10.1097/JSM.0000000000000930.
PMID: 34267064BACKGROUNDLee TG, Ahmad TS. Intralesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis. A prospective, randomized, controlled trial. Foot Ankle Int. 2007 Sep;28(9):984-90. doi: 10.3113/FAI.2007.0984.
PMID: 17880872BACKGROUNDKarimzadeh A, Raeissadat SA, Erfani Fam S, Sedighipour L, Babaei-Ghazani A. Autologous whole blood versus corticosteroid local injection in treatment of plantar fasciitis: A randomized, controlled multicenter clinical trial. Clin Rheumatol. 2017 Mar;36(3):661-669. doi: 10.1007/s10067-016-3484-6. Epub 2016 Dec 12.
PMID: 27957618BACKGROUNDTsikopoulos K, Tsikopoulos A, Natsis K. Autologous whole blood or corticosteroid injections for the treatment of epicondylopathy and plantar fasciopathy? A systematic review and meta-analysis of randomized controlled trials. Phys Ther Sport. 2016 Nov;22:114-122. doi: 10.1016/j.ptsp.2016.02.002. Epub 2016 Feb 24.
PMID: 27085490BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Celalettin Bildik, MD
Istanbul Atasehir Florence Nightingale Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedics and Traumatology Specialist
Study Record Dates
First Submitted
February 13, 2022
First Posted
February 15, 2022
Study Start
March 1, 2020
Primary Completion
October 30, 2020
Study Completion
January 15, 2022
Last Updated
March 2, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After acceptance to publish
- Access Criteria
- permission of Institutional Review of Board and Ethical Committee
According to permission of Institutional Review of Board and Ethical Committee; Participating demographics, outcome measures may be shared